# CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)

Study · id `cardio:ct-nct07220304` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07220304](<https://clinicaltrials.gov/study/NCT07220304>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07220304

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 15000 participants.

## Technical summary

Registry record NCT07220304. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-12 (anticipated); primary completion 2028-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 15000 participants (planned count; ClinicalTrials.gov record NCT07220304, source copy `cardio:ctgov-nct07220304-2025-10-23`, retrieved 2026-10-26)
- Planned start: 2025-12 (anticipated) (ClinicalTrials.gov record NCT07220304, source copy `cardio:ctgov-nct07220304-2025-10-23`, retrieved 2026-10-26)
- Primary completion: 2028-01 (anticipated) (ClinicalTrials.gov record NCT07220304, source copy `cardio:ctgov-nct07220304-2025-10-23`, retrieved 2026-10-26)
- Completion: 2028-07 (anticipated) (ClinicalTrials.gov record NCT07220304, source copy `cardio:ctgov-nct07220304-2025-10-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07220304, source copy `cardio:ctgov-nct07220304-2025-10-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07220304-2025-10-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)
- Acronym: CARE-CCTA
- Condition: Coronary Artery Disease
- Condition: Atherosclerosis
- Condition: Cardiovascular Inflammation
- Intervention (Device): CaRi-Heart® Analysis
- Lead sponsor: Corazon Medical PC
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: d32377577960b42ebb2f795720c59efce76407429ae930d818b2387d57fb770b
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
